The ITGB2‐COPS3‐SOX2 Axis and SOX2 Liquid‐Liquid Phase Separation: Dual Mechanisms Governing Osteosarcoma Stemness
Advanced Science · 2026
DOI: 10.1002/advs.202520913 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Lei Guo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Peking University First Hospital, Peking University, Beijing, China. Hauptthemen laut MEDLINE: Osteosarcoma, SOXB1 Transcription Factors, Neoplastic Stem Cells, Bone Neoplasms. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Beijing, China, National High Level Hospital Clinical Research Funding.
Abstract (Originalsprache)
Osteosarcoma is a highly malignant bone tumor prevalent in adolescents, whose therapeutic challenges stem largely from cancer stem cell (CSC)‐mediated chemoresistance and pulmonary metastasis. High‐frequency amplification of the 17p11.2 chromosomal region in osteosarcoma represents a key molecular event driving malignant progression. This study focuses on the key gene COPS3 in this region, delving into its molecular mechanisms regulating cancer stemness. The findings show that elevated COPS3 expression strongly correlates with stemness features. Mechanistically, COPS3 binds directly to transcription factor SOX2, inhibiting its ubiquitin‐mediated degradation, enhancing its stability and transcriptional activity, and establishing a positive feedback loop that reinforces the stemness phenotype. Furthermore, the extracellular matrix receptor ITGB2 emerges as an upstream regulator promoting COPS3 nuclear translocation. Significantly, this study provides the first evidence that SOX2 undergoes liquid‐liquid phase separation (LLPS) in osteosarcoma, a critical mechanism for maintaining cancer stemness. Based on these findings, we identified Z‐5891, a highly selective COPS3 inhibitor that suppresses tumor growth and reduces cancer stemness in vitro and in vivo. This study delineates a complete stemness regulatory pathway from microenvironmental signals to nuclear LLPS, thereby providing a novel theoretical framework and a candidate drug for targeting CSCs to overcome drug resistance and metastasis in osteosarcoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, Peking University First Hospital, Peking University, Beijing, China.
- Musculoskeletal Tumor Center, Peking University People's Hospital, Peking University, Beijing, China.
- Beijing Key Laboratory of Musculoskeletal Tumor, Beijing, China.
ORCID-Profile: Taiqiang Yan
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Beijing, China
- National High Level Hospital Clinical Research Funding
Zitieren
APA
Guo, L., Zhao, Z., Wang, W., Niu, J., Wang, B., Lin, Y., Guo, W., & Yan, T. (2026). The ITGB2‐COPS3‐SOX2 Axis and SOX2 Liquid‐Liquid Phase Separation: Dual Mechanisms Governing Osteosarcoma Stemness. Advanced Science. https://doi.org/10.1002/advs.202520913
Vancouver
Guo L, Zhao Z, Wang W, Niu J, Wang B, Lin Y, et al. The ITGB2‐COPS3‐SOX2 Axis and SOX2 Liquid‐Liquid Phase Separation: Dual Mechanisms Governing Osteosarcoma Stemness. Advanced Science. 2026. doi:10.1002/advs.202520913
BibTeX
@article{Guo2026,
author = {Guo, Lei and Zhao, Zhiqing and Wang, Wei and Niu, Jianfang and Wang, Bing and Lin, Yunfei and Guo, Wei and Yan, Taiqiang},
title = {The ITGB2‐COPS3‐SOX2 Axis and SOX2 Liquid‐Liquid Phase Separation: Dual Mechanisms Governing Osteosarcoma Stemness},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202520913}
}
EUVIMED